Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity

PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

March 16, 2020

Study Completion Date

July 31, 2020

Conditions
Hypothalamic Obesity
Interventions
DRUG

Exenatide

Weekly injections of active drug.

DRUG

placebo

Weekly placebo injections

Trial Locations (3)

37235

Vanderbilt University School of Medicine, Nashville

55404

Children's Hospitals adn Clinics of Minnesota, Minneapolis

98105

Seattle Childrens, Seattle

All Listed Sponsors
collaborator

Children's Hospitals and Clinics of Minnesota

OTHER

collaborator

Vanderbilt University

OTHER

lead

Seattle Children's Hospital

OTHER

NCT02664441 - Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity | Biotech Hunter | Biotech Hunter